Efficacy of OSFIT Drug-Eluting Stent in Coronary Ostial Artery Stenosis

The purpose of this observational study is to evaluate the long-term effectiveness and safety of the OSFIT drug-eluting stent designed to facilitate procedures in coronary artery lesions. Additionally, the study aims to verify the accuracy of stent placement in the lesion of interest using Optical Coherence Tomography (OCT) among subgroups of participants. The primary endpoint was defined as the composite of target lesion failure (TLF) at the 12-month mark, including cardiac death, target vessel myocardial infarction (MI), or target lesion revascularization.

NCT Number	NCT06066450
Lead Sponsor	Genoss Co., Ltd.
Conditions	Drug-eluting Stent, Coronary Artery Disease
Enrollment	1,000 participants
Start Date	2023-07-07
Primary Completion	2026-12-31 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2023-11-01